FDA Withdraws Approval of New Animal Drug Application for Bacitracin Zinc

Summary

The Food and Drug Administration (FDA) is amending its animal drug regulations to remove the approval of a new animal drug application (NADA) for a bacitracin zinc Type A medicated article, which was previously withdrawn.